Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfann, K. D.
Right arrow Articles by Corcos, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfann, K. D.
Right arrow Articles by Corcos, D. M.
NEUROLOGY 1998;51:796-803
© 1998 American Academy of Neurology

Pallidotomy and bradykinesia

Implications for basal ganglia function

Kerstin D. Pfann, PhD, Richard D. Penn, MD, Kathleen M. Shannon, MD and Daniel M. Corcos, PhD

From the School of Kinesiology (M/C 194; Drs. Pfann and Corcos) and the Department of Psychology (Dr. Corcos), University of Illinois at Chicago; and the Departments of Neurosurgery (Dr. Penn) and Neurological Sciences (Drs. Shannon and Corcos), Rush Medical College, Chicago, IL.

Address correspondence and reprint requests to Dr. Kerstin Pfann, School of Kinesiology, University of Illinois at Chicago, 901 W. Roosevelt Road, Chicago, IL 60608-1516.

Background and Objective: The scientific rationale for pallidotomy as a treatment for PD is that the lesion will reduce excessive tonic inhibition of the thalamus, thereby allowing movement to proceed more normally. If true, then PD patients who move slowly while on medication should increase movement speed following pallidotomy. To test this we used a simple motor task to determine if pallidotomy leads to an improvement in "on" motor performance when those movements are impaired before surgery.

Methods: Nine patients with PD performed elbow flexion movements "as fast as possible" while they were "on" before and 1 month after pallidotomy. Patients with mild PD and healthy control subjects were also tested.

Results: The clinical effects of pallidotomy were typical of those found in other studies. "Off" Unified Parkinson's Disease Rating Scale scores improved and dyskinesias were reduced. Although before surgery the patients were far slower while they were "on" than the groups of mild PD patients and healthy control subjects, there was no change in mean peak velocity while they were"on" after pallidotomy. There was no change in other mean "on" motor performance measures such as peak acceleration, peak deceleration, initiation time, and symmetry. There was a decrease in the variability of peak acceleration, symmetry, and initiation time.

Conclusion: Despite the clinical efficacy of pallidotomy while patients were "off", bradykinesia of elbow flexion movements while patients were "on" is not affected by pallidotomy. Therefore, we conclude that the bradykinesia observed in this experiment is due to a mechanism other than excessive tonic inhibition of the motor thalamus. Our results are consistent with the idea that pallidotomy reduces the noise from the abnormally functioning basal ganglia.


Supported in part by the National Institute of Neurological and Communicative Disorders and Stroke grants K04-NS 01508 and R01-NS 28127, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01-AR 33189.

Received January 22, 1998. Accepted in final form May 16, 1998.




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
M. Desmurget and R. S. Turner
Testing Basal Ganglia Motor Functions Through Reversible Inactivations in the Posterior Internal Globus Pallidus
J Neurophysiol, March 1, 2008; 99(3): 1057 - 1076.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
J. B. Lohr and M. P. Caligiuri
Abnormalities in Motor Physiology in Bipolar Disorder
J Neuropsychiatry Clin Neurosci, August 1, 2006; 18(3): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. E. Vaillancourt, J. Prodoehl, L. Verhagen Metman, R. A. Bakay, and D. M. Corcos
Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease
Brain, March 1, 2004; 127(3): 491 - 504.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Berardelli, J. C. Rothwell, P. D. Thompson, and M. Hallett
Pathophysiology of bradykinesia in Parkinson's disease
Brain, November 1, 2001; 124(11): 2131 - 2146.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P K Pal, A Samii, A Kishore, M Schulzer, E Mak, S Yardley, I M Turnbull, and D B Calne
Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years
J. Neurol. Neurosurg. Psychiatry, September 1, 2000; 69(3): 337 - 344.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.